Albuterol Sulfate Inhalant
Product Images NDC 17270-0740

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 17270-0740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armstrong Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
Packaging label for Albuterol Sulfate Inhalation Aerosol 90 mcg per actuation by Armstrong Pharmaceuticals, Inc. The label states the product is for oral inhalation and dispenser contains 200 metered inhalations. It includes directions indicating the inhaler delivers 90 mcg of active ingredient per actuation. The label warns to read the patient leaflet for full instructions and prescribing information and advises dosage as directed by a physician. Expiration and lot number placeholders are displayed. A dose counter is featured on two panels.*
FDA Label Image

Figurec (Figurec)

Figurec (Figurec)
An instructional illustration showing a person using an inhalant device by holding it near their mouth and pressing down to release a spray. The image is labeled "Figure C."*
FDA Label Image

Figured (Figured)

Figured (Figured)
An instructional diagram showing the dose counter window on an Albuterol Sulfate inhalant device, indicating the remaining number of doses as 200. The diagram highlights the location of the dose counter with an arrow and label.*
FDA Label Image

Figuree (Figuree)

Figuree (Figuree)
An instructional illustration showing the proper mouthpiece-down position for using an Albuterol Sulfate inhalant. The image depicts a hand holding the inhaler with the mouthpiece pointed downward while removing or holding the cap, labeled as Figure E.*
FDA Label Image

Figuref (Figuref)

Figuref (Figuref)
An instructional illustration showing a person using an inhalant device. The person is depicted pressing down on the inhaler while inhaling, with the text 'Push down and breathe in.' indicating how to properly use the device for respiratory drug administration.*
FDA Label Image

Figuregh (Figuregh)

Figuregh (Figuregh)
An instructional diagram showing two hand-held images of an inhaler. The left image labeled 'Blocked' demonstrates that when the inhaler spray is blocked, little or no medicine is released. The right image labeled 'Not Blocked' shows proper use with medicine being released unobstructed from the inhaler.*
FDA Label Image

Figurei (Figurei)

Figurei (Figurei)
An instructional illustration showing a hand holding an Albuterol Sulfate inhaler mouthpiece under a running faucet. Water sprays onto the mouthpiece with accompanying text instructing to wash the mouthpiece under warm running water.*
FDA Label Image

Figurej (Figurej)

Figurej (Figurej)
An instructional illustration showing the cleaning of an inhalant mouthpiece under running water. A hand holds the Albuterol Sulfate inhaler mouthpiece beneath a faucet with water flowing over it, demonstrating proper inhaler maintenance technique.*
FDA Label Image

Figurek (Figurek)

Figurek (Figurek)
An instructional illustration showing four panels: the top left panel contains a crescent moon, possibly representing nighttime; the top right panel is blank. The bottom panels depict a small bottle with a dropper and an inhaler device, emphasizing that the mouthpiece should be allowed to dry, such as overnight. A cap for the mouthpiece is also shown. This diagram is intended to guide the proper drying of the inhaler mouthpiece.*
FDA Label Image

Figureab (Figuresab)

Figureab (Figuresab)
An instructional illustration depicting components of an Albuterol Sulfate inhalant. Figure A shows the metal canister, plastic actuator, mouthpiece, and cap. Figure B highlights the dose counter on the side of the inhaler device.*
FDA Label Image

Image Description (Graph)

Image Description (Graph)
Two line graphs showing the mean percent change in FEV1 from pre-dose over a 6-hour period on Day 1 and Day 43 in a 6-week clinical trial. The graphs compare Albuterol Sulfate HFA Inhalation Aerosol, matched placebo HFA Inhalation Aerosol, and a marketed HFA-134a Albuterol Inhaler in terms of lung function response over time.*
FDA Label Image

Image Description (Structureimage)

Image Description (Structureimage)
Chemical structure diagram of Albuterol Sulfate, showing its molecular components including hydroxyl groups, an aromatic ring, and a sulfate moiety with associated ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.